- Home
- KYMR vs GTES Comparison
KYMR vs GTES Comparison
Compare KYMR & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | GTES |
|---|---|---|
| Founded | 2015 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.9B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | KYMR | GTES |
|---|---|---|
| Price | $84.99 | $25.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 9 |
| Target Price | ★ $107.72 | $28.56 |
| AVG Volume (30 Days) | 507.7K | ★ 2.0M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.73 |
| EPS | N/A | ★ 0.96 |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | $5.83 |
| Revenue Next Year | $8.17 | $3.95 |
| P/E Ratio | ★ N/A | $26.54 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.06 | $17.79 |
| 52 Week High | $103.00 | $28.47 |
Technical Indicators
Market Signals| Indicator | KYMR | GTES |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 55.97 |
| Support Level | $77.78 | $24.02 |
| Resistance Level | $90.15 | $26.10 |
| Average True Range (ATR) | 3.06 | 0.83 |
| MACD | -0.18 | 0.14 |
| Stochastic Oscillator | 29.50 | 72.83 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About GTES Gates Industrial Corporation plc
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.